ROME, June 15 -- Italy, along with some European partners, signed a contract with AstraZeneca pharmaceutical company for buying up to 400 million doses of a potential coronavirus vaccine, a top health official confirmed on Monday.
The contract with the British-Swedish pharmaceutical followed a deal agreed between Italy, Germany, France, and the Netherlands in the previous days in order to ensure the availability of the vaccine in the European markets, once ready.
"Italy has not yet purchased doses of the vaccine -- which are not yet available -- but rather signed a contract to keep supporting this scientific research," Italy's Deputy Health Minister Pierpaolo Sileri told state-run RAI Radio 1.
"Presuming to have it ready for autumn may be premature, yet it (the vaccine) could arrive by the end of the year, or beginning of 2021," he added.
On Saturday, Health Minister Roberto Speranza anticipated the finalization of the deal with the three above-mentioned European Union (EU) partners, within a sort of "vaccination alliance" to financially support what was deemed as one of the most encouraging vaccine research -- the AstraZeneca's -- and thus to be ready for promptly purchasing the drug in a later phase.
"Along with Germany, France, and the Netherlands, I have just signed the first deal for the supply of up to 400 million doses of the most promising COVID-19 vaccine to be destined to the whole European population," Speranza wrote on Twitter and Facebook.
His comments were later republished in a ministry's statement on the same day.
"This potential vaccine stems from studies of the Oxford University, and it will involve relevant Italian entities in the phases of development and production," Speranza explained.
The minister added the commitment underneath the contract provided that the trial path, already in an advanced phase, would end in autumn, "with the distribution of the first tranche of doses by the end of the year."
In an interview to Rai 3 TV Agora broadcast on Monday, AstraZeneca Chief Executive Officer Lorenzo Wittum confirmed that clinical trials of the potential COVID-19 vaccine were going through the last phase.
"As long as we will not have the results of tests on human beings, which will occur in September, we will not be able to state this vaccine is effective," Wittum specified.
Yet, he added, they were "confident it would work ... All went well in the first phases (of the trial), and now we are testing it on some thousand volunteers to verify it effectively protects from the contagion."
As for the economic availability of the drug, once ready, the AstraZeneca CEO explained, the company has committed to producing some 2 billion doses with the aim of ensuring a "broad, fair, and uNPRofitable access during the pandemic."
"The costs for distributing the vaccine will be of few euros," he said.
雅思词汇背诵技巧
专家总结背诵雅思单词的方法
如何选择合适的雅思词汇手册?
雅思单词:从词典中解放出来
英汉词典能帮我们学会什么
背单词最高境界:像“广告”一样背单词
雅思词汇如何过目不忘:废物时间法
雅思单词背诵:“少吃多餐”加“零敲碎打”
对付雅思考试中的生词可以用哪些手段
如何处理雅思听力题干中的生词?
雅思词汇:如何过目不忘-废物时间法
如何巧破雅思考试单词5000大关
雅思高分怪招:单词分类综合学习法(1)
破除雅思背单词难的魔咒
雅思高分怪招:单词分类综合学习法(2)
雅思写作:地图题的写法
雅思考试背单词方法之谐音法
征服海量词汇“烤鸭”如何选择性记忆
背雅思单词其实也很轻松之对比法
5个记忆初级英语单词的最有效方法
七招搞定雅思阅读拦路虎—生词
你不得不学的英语单词快速记忆法
海量词汇,如何有针对性的记忆?
如何短期内突破2011雅思词汇?
如何高效积累雅思词汇-阅读篇
背雅思单词秘笈:像广告一样高频重复记忆
雅思单词记忆小技巧
专家秘籍:如何储备雅思阅读词汇
雅思初级单词怎么背最有效
如何用20天轻松攻克雅思单词
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |